Bailly C, Thuru X, Quesnel B. Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times. NAR Cancer. 2020 Feb 17;2(1):zcaa002. https://doi.org/10.1093/narcan/zcaa002. PMID: 34316682; PMCID: PMC8209987.

Marupudi NI, et al. Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf. 2007;6(5):609–21.

Article  CAS  PubMed  Google Scholar 

Chou PL, Huang YP, Cheng MH, Rau KM, Fang YP. Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis. Int J Nanomedicine. 2020 Mar 12;15:1731–1743. https://doi.org/10.2147/IJN.S231407. PMID: 32210563; PMCID: PMC7075337.

Zhang H, et al. Iridium oxide nanoparticles-based theranostic probe for in vivo tumor imaging and synergistic chem/photothermal treatments of cancer cells. Chem Eng J. 2022;430:132675.

Article  CAS  Google Scholar 

Zhou Y, et al. Upconverting nanoparticles based nanodevice for DNAzymes amplified miRNAs detection and artificially controlled chemo-gene therapy. Biosens Bioelectron. 2022;214:114549.

Article  CAS  PubMed  Google Scholar 

Qiu L, et al. A targeted, self-delivered, and photocontrolled molecular beacon for mRNA detection in living cells. J Am Chem Soc. 2013;135(35):12952–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yan J, et al. Therapeutic DNAzymes: from structure design to clinical applications. Adv Mater. 2023: p. 2300374.

Mueller SN, et al. PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice. J Clin Investig. 2010;120(7):2508–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bartlett DW, Davis ME. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing. Biotechnol Bioeng. 2007;97(4):909–21.

Article  CAS  PubMed  Google Scholar 

Volkov AA, et al. Selective protection of nuclease-sensitive sites in siRNA prolongs silencing effect. Oligonucleotides. 2009;19(2):191–202.

Article  CAS  PubMed  Google Scholar 

Lee JM, Yoon TJ, Cho YS. Recent developments in nanoparticle-based siRNA delivery for cancer therapy. Biomed Res Int. 2013;2013:782041. https://doi.org/10.1155/2013/782041. Epub 2013 Jun 17. PMID: 23844368; PMCID: PMC3703404.

Tomar RS, Matta H, Chaudhary PM. Use of adeno-associated viral vector for delivery of small interfering RNA. Oncogene. 2003;22(36):5712–5.

Article  CAS  PubMed  Google Scholar 

Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003;4(5):346–58.

Article  CAS  PubMed  Google Scholar 

Emens LA, Middleton G. The interplay of immunotherapy and chemotherapy: harnessing potential synergies. Cancer Immunol Res. 2015;3(5):436–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanoteau A, Moser M. Chemotherapy and immunotherapy: a close interplay to fight cancer? Oncoimmunology. 2016;5(7):e1190061.

Article  PubMed  PubMed Central  Google Scholar 

Attia MF, et al. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol. 2019;71(8):1185–98.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Cao J, Yuan Z. Strategies and challenges to improve the performance of tumor-associated active targeting. J Mater Chem B. 2020;8(18):3959–71.

Article  CAS  PubMed  Google Scholar 

Thiramanas R, et al. Cellular uptake of siRNA-loaded nanocarriers to knockdown PD-L1: strategies to improve T-cell functions. Cells. 2020;9(9):2043.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Y, et al. Silencing PD-1 and PD-L1 with nanoparticle-delivered small interfering RNA increases cytotoxicity of tumor-infiltrating lymphocytes. Nanomedicine. 2019;14(8):955–67.

Article  CAS  PubMed  Google Scholar 

Islam T, Josephson L. Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles. Cancer Biomark. 2009;5(2):99–107.

Article  CAS  PubMed  Google Scholar 

Chen L, et al. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia. Acta Biomater. 2019;96:491–504.

Article  CAS  PubMed  Google Scholar 

Palanisamy S, Wang YM. Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer. Dalton Trans. 2019;48(26):9490–515.

Article  CAS  PubMed  Google Scholar 

Zhang MW, et al. Controlled fabrication of iron oxide/mesoporous silica core-shell nanostructures. J Phys Chem C. 2013;117(41):21529–38.

Article  CAS  Google Scholar 

Gupta A, et al. Nanocarrier composed of magnetite core coated with three polymeric shells mediates LCS-1 delivery for synthetic lethal therapy of BLM-defective colorectal cancer cells. Biomacromol. 2018;19(3):803–15.

Article  CAS  Google Scholar 

Ahmad A, et al. Hyperbranched polymer-functionalized magnetic nanoparticle-mediated hyperthermia and niclosamide bimodal therapy of colorectal cancer cells. ACS Biomater Sci Eng. 2020;6(2):1102–11.

Article  CAS  PubMed  Google Scholar 

Hariani PL, et al. Synthesis and properties of Fe3O4 nanoparticles by co-precipitation method to removal procion dye. Int J Environ Sci Dev. 2013;4(3):336–40.

Article  CAS  Google Scholar 

Tang H, et al. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery. Int J Pharm. 2011;421(2):388–96.

Article  CAS  PubMed  Google Scholar 

Saini K, Bandyopadhyaya R. Transferrin-conjugated polymer-coated mesoporous silica nanoparticles loaded with gemcitabine for killing pancreatic cancer cells. ACS Applied Nano Materials. 2019;3(1):229–40.

Article  Google Scholar 

Wei Y, et al. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy. Drug Delivery. 2017;24(1):681–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan A, et al. Remote and local control of stimuli responsive materials for therapeutic applications. Adv Drug Deliv Rev. 2013;65(4):497–514.

Article  CAS  PubMed  Google Scholar 

Hernández-Hernández AA, et al. Iron oxide nanoparticles: synthesis, functionalization, and applications in diagnosis and treatment of cancer. Chem Pap. 2020;74(11):3809–24.

Article  Google Scholar 

Makadia HK, Siegel SJ. Poly lactic–glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3):1377–97.

Article  CAS  PubMed  Google Scholar 

Goyal AK, et al. Application and perspective of pH-responsive nano drug delivery systems. In: Applications of Targeted Nano Drugs and Delivery Systems. Elsevier; 2019. p. 15–33.

Chapter  Google Scholar 

Khing TM, et al. The effect of paclitaxel on apoptosis, autophagy and mitotic catastrophe in AGS cells. Sci Rep. 2021;11(1):23490.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Callahan MK, Postow MA, Wolchok JD. Targeting T cell co-receptors for cancer therapy. Immunity. 2016;44(5):1069–78.

Article  CAS  PubMed